XML 69 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Reportable Segment Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net sales:        
Net sales $ 1,198,773 $ 1,291,568 $ 2,546,090 $ 2,588,970
Segment profit:        
Operating profit 119,370 199,937 315,592 363,807
Restructuring and other charges, net (1,884) (2,525) (6,802) (18,699)
Losses on sale of assets (399) (952) (1,153) (764)
Interest expense (32,062) (32,593) (64,202) (69,165)
Other income, net 15,757 2,137 5,183 9,415
Income before taxes 103,065 169,481 256,573 304,057
Taste        
Net sales:        
Net sales 748,324 811,319 1,578,646 1,616,121
Scent        
Net sales:        
Net sales 450,449 480,249 967,444 972,849
Corporate and Other        
Segment profit:        
Operational improvement initiative costs 0 (534) 0 (940)
Restructuring and other charges, net (1,884) (2,525) (6,802) (18,699)
Losses on sale of assets (399) (952) (1,153) (764)
Frutarom Acquisition Related Costs 239 1,433 (574) (8,096)
FDA Mandated Product Recall 25 0 (624) 0
Operating Segments | Taste        
Net sales:        
Net sales 748,324 811,319 1,578,646 1,616,121
Segment profit:        
Operating profit 107,276 130,623 244,623 262,025
Operating Segments | Scent        
Net sales:        
Net sales 450,449 480,249 967,444 972,849
Segment profit:        
Operating profit 70,373 94,214 175,768 184,167
Corporate, Non-Segment        
Segment profit:        
Operating profit (19,549) (10,905) (39,942) (27,572)
Nutrition & Biosciences, Inc | Corporate and Other        
Segment profit:        
Integration-related costs (22,502) 0 (32,646) 0
Transaction related costs (10,926) 0 (16,125) 0
Frutarom | Corporate and Other        
Segment profit:        
Integration-related costs $ (3,283) $ (11,417) $ (6,933) $ (26,314)